Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Natco Pharma seeks CDSCO emergency nod for Covid drug Molnupiravir

Ruchika Sharma27 April 2021 12:27 PM IST

Hyderabad: Drugmaker, Natco Pharma Limited, has recently announced that the company has applied to the Central Drugs Standard Control...

Optimus Pharma Anti-Parkinson's drug Safinamide gets DCGI okay

Ruchika Sharma27 April 2021 12:10 PM IST

Hyderabad: Optimus Pharma has announced that it has received DCGI approval for its Anti-Parkinson's drug Safinamide. Safinamide is indicated as...

Glenmark Pharma secures European approval for Ryaltris nasal spray to treat allergic rhinitis

Ruchika Sharma27 April 2021 10:00 AM IST

Mumbai: Glenmark Pharmaceuticals Limited has recently announced that the company is concluding the final, national phase of its marketing approval...

SciClone Pharma tests hepatitis drug as coronavirus vaccine enhancer

Ruchika Sharma27 April 2021 9:00 AM IST

New Delhi: China's SciClone Pharmaceuticals has begun a clinical trial to test if its hepatitis B treatment Zadaxin helps to boost immunity provided...

Biocon Biologics, Viatris get EC approval for Abevmy

Ruchika Sharma26 April 2021 3:29 PM IST

Bengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has announced that Abevmy 100 & 400 mg, a biosimilar of Bevacizumab co-developed...

CDSCO nod to Biological E Covid vaccine Phase 3 trial

Ruchika Sharma26 April 2021 1:04 PM IST

Hyderabad: Pharma major, Biological E. Limited, has recently announced that the company has successfully completed the Phase I/II clinical trial of...

Bharat Biotech seeks DCGI nod for extension of Covaxin shelf life from 6 to 24 months

Ruchika Sharma26 April 2021 12:48 PM IST

New Delhi: Bharat Biotech has written to India's drug regulator seeking extension of the shelf-life of its indigenously developed Covid-19 vaccine...

Sun Pharma, Lupin, Jubilant Cadista recall products in US

Ruchika Sharma26 April 2021 11:52 AM IST

New Delhi: Leading generic drug makers Lupin, Sun Pharma and Jubilant Cadista are recalling different products in the US, the world''s largest...

Low-Risk Medical Device Makers Get Clarity: CDSCO Publishes Class A Risk Classification List under MDR 2017

With covid triggering market penetration, Morepen labs betting big on diagnostics devices segment

Ruchika Sharma26 April 2021 10:00 AM IST

New Delhi: Drug firm Morepen Laboratories is betting big on the diagnostics devices segment going forward while building its presence in the active...

USFDA grants EUA to Thermo Fisher Scientific's Amplitude Solution for COVID-19 testing

Ruchika Sharma25 April 2021 11:30 AM IST

Mumbai: Thermo Fisher Scientific, the world leader in serving science, received emergency use authorization (EUA) from the U.S. Food and Drug...

Apex Labs gets govt nod to CleVira as Covid supportive drug

Ruchika Sharma25 April 2021 11:00 AM IST

Chennai: City based pharma company Apex Laboratories will take the doctor's prescription route for its oral antiviral CleVira tablet that got the...

Johnson and Johnson single-shot Covid-19 vaccine expected in India by July: Report

Ruchika Sharma25 April 2021 10:00 AM IST

New Delhi: Johnson & Johnson's single-shot Covid-19 vaccine is expected to be imported to India for "fill and finish" by June or July, financial...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok